JP2022535734A5 - - Google Patents

Info

Publication number
JP2022535734A5
JP2022535734A5 JP2021570274A JP2021570274A JP2022535734A5 JP 2022535734 A5 JP2022535734 A5 JP 2022535734A5 JP 2021570274 A JP2021570274 A JP 2021570274A JP 2021570274 A JP2021570274 A JP 2021570274A JP 2022535734 A5 JP2022535734 A5 JP 2022535734A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
aromatic ring
formula
bicyclic aromatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021570274A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535734A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/034643 external-priority patent/WO2020243135A1/en
Publication of JP2022535734A publication Critical patent/JP2022535734A/ja
Publication of JP2022535734A5 publication Critical patent/JP2022535734A5/ja
Pending legal-status Critical Current

Links

JP2021570274A 2019-05-28 2020-05-27 縮合複素環誘導体 Pending JP2022535734A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962853533P 2019-05-28 2019-05-28
US62/853,533 2019-05-28
EP19176933.0 2019-05-28
EP19176933 2019-05-28
CN2020085720 2020-04-20
CNPCT/CN2020/085720 2020-04-20
PCT/US2020/034643 WO2020243135A1 (en) 2019-05-28 2020-05-27 Fused heterocyclic derivatives

Publications (2)

Publication Number Publication Date
JP2022535734A JP2022535734A (ja) 2022-08-10
JP2022535734A5 true JP2022535734A5 (cg-RX-API-DMAC7.html) 2023-06-05

Family

ID=71741889

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021570274A Pending JP2022535734A (ja) 2019-05-28 2020-05-27 縮合複素環誘導体

Country Status (19)

Country Link
EP (1) EP3976617B1 (cg-RX-API-DMAC7.html)
JP (1) JP2022535734A (cg-RX-API-DMAC7.html)
KR (1) KR20220012913A (cg-RX-API-DMAC7.html)
CN (1) CN113906028A (cg-RX-API-DMAC7.html)
AU (1) AU2020285718A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021022889A8 (cg-RX-API-DMAC7.html)
CA (1) CA3138168A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021003155A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021016433A2 (cg-RX-API-DMAC7.html)
CR (1) CR20210666A (cg-RX-API-DMAC7.html)
DO (1) DOP2021000230A (cg-RX-API-DMAC7.html)
IL (1) IL288322A (cg-RX-API-DMAC7.html)
JO (1) JOP20210313A1 (cg-RX-API-DMAC7.html)
MA (1) MA56043A (cg-RX-API-DMAC7.html)
MX (1) MX2021014575A (cg-RX-API-DMAC7.html)
PE (1) PE20220767A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021552974A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202113167QA (cg-RX-API-DMAC7.html)
WO (1) WO2020243135A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022116999A1 (en) * 2020-12-02 2022-06-09 Janssen Sciences Ireland Unlimited Company Fused heterocyclic derivatives and their use in the treatment of hbv infection
WO2022116998A1 (en) * 2020-12-02 2022-06-09 Janssen Sciences Ireland Unlimited Company Fused heterocyclic derivatives as hbv inhibitors
TW202237617A (zh) * 2020-12-02 2022-10-01 愛爾蘭商健生科學愛爾蘭無限公司 稠合雜環衍生物
AR126049A1 (es) 2021-06-02 2023-09-06 Janssen Sciences Ireland Unlimited Co Derivados heterocíclicos condensados
CA3218641A1 (en) * 2021-06-02 2022-12-08 Chunliang Lu Fused heterocyclic derivatives
WO2024114709A1 (en) * 2022-12-01 2024-06-06 Janssen Sciences Ireland Unlimited Company A crystal form of a fused heterocycle derivative compound
WO2024140851A1 (zh) * 2022-12-28 2024-07-04 上海维申医药有限公司 一类Toll样受体抑制剂及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2993174A1 (en) * 2014-09-08 2016-03-09 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH Pyrazolopyridine derivatives and their use in therapy
WO2016109689A2 (en) * 2014-12-30 2016-07-07 Novira Therapeutics, Inc. Derivatives and methods of treating hepatitis b infections
CA3029566A1 (en) * 2016-06-29 2018-01-04 Novira Therapeutics, Inc. Diazepinone derivatives and their use in the treatment of hepatitis b infections
TW201806956A (zh) * 2016-06-29 2018-03-01 諾維拉治療公司 二氮呯酮衍生物及治療b型肝炎感染之方法
US20220306647A1 (en) * 2019-04-30 2022-09-29 Aicuris Gmbh & Co. Kg Novel indole-2-carboxamides active against the hepatitus b virus (hbv)

Similar Documents

Publication Publication Date Title
JP2022509533A5 (cg-RX-API-DMAC7.html)
CN111788204B (zh) 作为hbv复制抑制剂的取代吡咯嗪化合物
US10875876B2 (en) Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
TWI329103B (en) Aminoindazole derivatives, preparation process and intermediates of this process as medicinal products, and pharmaceutical compositions containing them
KR102271574B1 (ko) 설파모일-아릴아미드 및 b형 간염 치료제로서의 그 용도
CN114430739A (zh) Egfr抑制剂、组合物及其制备方法
JP2021512150A5 (cg-RX-API-DMAC7.html)
JP2011509309A5 (cg-RX-API-DMAC7.html)
JP2017525757A5 (cg-RX-API-DMAC7.html)
JP4324791B2 (ja) 2−アシルアミノチアゾール誘導体又はその塩
JP2016529324A5 (cg-RX-API-DMAC7.html)
JP2022505841A5 (cg-RX-API-DMAC7.html)
CN1378541A (zh) c-JUN N-末端激酶(JNK)和其它蛋白激酶的抑制剂
JP2014508720A5 (cg-RX-API-DMAC7.html)
JP2015526448A5 (cg-RX-API-DMAC7.html)
JP2014526500A5 (cg-RX-API-DMAC7.html)
JP2012503018A5 (cg-RX-API-DMAC7.html)
JP5941598B2 (ja) 5員ヘテロアリールおよびそれらの抗ウイルス剤としての使用
JP2022501370A5 (cg-RX-API-DMAC7.html)
JP2019507114A5 (cg-RX-API-DMAC7.html)
JP2006507355A5 (cg-RX-API-DMAC7.html)
US20230133504A1 (en) Method of treating graft-versus-host disease
JP2021523109A5 (cg-RX-API-DMAC7.html)
JP2022522312A (ja) ピロール化合物
JP2021523108A5 (cg-RX-API-DMAC7.html)